ViewRay, Inc. has announced that the company’s MRIdian System is the focus of more than 40 abstracts selected by the American Association of Physicists in Medicine (AAPM) for presentation during their 2019 Annual Meeting July 14-18 in San Antonio, Texas.
MRI-guided radiotherapy will be highlighted in a number of abstracts and posters throughout the scientific program at AAPM 2019, illustrating the growing interest in this treatment approach. The MRIdian-specific research being presented will cover topics including motion prediction, quality assurance, stereotactic body radiation therapy, adaptive therapy, and tumor response assessment.
These abstracts feature MRIdian experience from global leaders such as Washington University School of Medicine in St. Louis; Henry Ford Health System (HFHS); University of California Los Angeles (UCLA); University of Wisconsin; Loyola University Medical Center, Chicago; University of Miami; Miami Cancer Institute at Baptist Health South Florida; Institute of Health Science at Acibadem University, Istanbul; Amsterdam University Medical Centers; The NewYork-Presbyterian Hospital; UF Health Cancer Center at Orlando Health; Institut Paoli-Calmettes, Marseille; Rigshospitalet Copenhagen; and Heidelberg University Hospital.
Noteworthy MRIdian abstracts featured in AAPM’s Scientific Program included data from an international consortium of 12 MRIdian centers that demonstrated excellent agreement in multi-institutional commissioning data. Three presentations that showcase the ability to use functional imaging on a low-field MRI. Research awarded the “Best in Physics (Multi-disciplinary)” designation, which is the first to highlight that quantitative T1 mapping is meaningful and Strategically Acquired Gradient Echo (STAGE) MRI is promising for functional brain cancer imaging at 0.35T.
AAPM attendees can learn more about MRIdian and MRI-Guided Real-time On-table Adaptive Radiotherapy (ROAR) in ViewRay’s booth #500. Presentations will be made in the company’s booth throughout the meeting by MRIdian clinical users from UCLA Health, Jonsson Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Carbone Cancer Center, University of Wisconsin – Madison; Miami Cancer Institute, Baptist Health South Florida; The NewYork-Presbyterian Hospital and Weill Cornell Medicine; and Loyola Center for Cancer Care & Research at Palos Health South Campus. Presenters will share their MRIdian experience and highlight topics such as the value of MRI-guided RT, real-time tracking and automated gating, optimal magnetic field strength for RT, adaptive therapy workflows, online quality assurance, program implementation, and clinical efficiencies.
The ViewRay booth will also feature demonstrations of the MRIdian System’s adaptive workflow, which helps to improve targeting precision and accuracy to deliver higher, and potentially more effective, radiation doses. Demos can be booked online in advance of AAPM or in-person at the booth during the meeting.
